Analysts Set Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Target Price at $187.71
Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) have received a consensus rating of “Moderate Buy” from the fourteen brokerages that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The average twelve-month target […]
Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) have received a consensus rating of “Moderate Buy” from the fourteen brokerages that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The average twelve-month target […]
